International Journal of Sport Nutrition and Exercise Metabolism, 2003, 13, 125-151
2003 Human Kinetics Publishers, Inc.
Introduction
Ascorbic acid, or vitamin C, is a six-carbon compound similar in structure to glucose. It exists in two active forms: the reduced form known as ascorbic acid and the
oxidized form, dehydroascorbic acid. The molecular structure contains two ionizable enolic hydrogen atoms that give the compound its acidic character (Figure 1;
54). Ascorbic acid is considered to be an outstanding antioxidant. Chemically,
ascorbic acid exhibits redox characteristics as a reducing agent. Physiologically,
ascorbic acid provides electrons for enzymes, for chemical compounds that are
oxidants, or other electron acceptors (91). The intermediate free radical formed in
J.M. Peake is with the School of Human Movement Studies at the University of
Queensland, St Lucia QLD 4072 Australia.
125
126 / Peake
Figure 1 Redox properties of ascorbic acid (modified with permission from 36).
Organ/fluid
Pituitary gland
Adrenal gland
Eye lens
Liver
Pancreas
Spleen
Kidney
Cardiac muscle
Brain
Lungs
Skeletal muscle
Plasma
and GLUT 3, the transport protein for ascorbic acid is yet to be identified. Substrate
availability is likely to be critical in determining which molecule (i.e., ascorbic acid
or dehydroascorbic acid) is transported at any particular time. Under non-oxidizing
conditions, ascorbate is present in greater amounts and is therefore more likely to be
transported. In contrast, when oxidants are present, ascorbate is oxidized, resulting
in the transient formation of dehydroascorbic acid (91). Now available to surrounding cells, dehydroascorbic acid is preferentially transported for intracellular reduction (91) either by enzymatic reduction (80) or glutathione (109). This recycling of
ascorbic acid is likely to be important under conditions of oxidative stress (91).
The redox properties of ascorbic acid (Figure 1) make it an effective reducing
agent in several important enzymatic reactions within the body, all of which require
that enzyme-bound metal ions are maintained in their reduced state (79). In the
adrenal gland ascorbic acid is stored in high concentrations where it is utilized by the
enzyme dopamine -monooxygenase within chromaffin granules to synthesize
noradrenaline (Figure 2A; 24). In the pituitary gland and the brain, ascorbic acid is
involved with the enzyme peptidyl-glycine -amidating monooxygenase (72) for
the activation of a variety of neuropeptides and hormone releasing-factors (Figure
2D; 79). The vitamin is required by the prolyl- and lysyl-hydroxylase enzymes for
the hydroxylation of proline and lysine residues, respectively, in the production of
collagen (Figure 2B; 12), and also by the enzymes 6-N-trimethyllysine hydroxylase
and -butyrobetaine hydroxylase in carnitine synthesis (Figure 2C; 74). This latter
role could possibly account for the ascorbic acid content of both cardiac and skeletal
muscle (74). In the liver, ascorbic acid is possibly involved in glucose (11), cholesterol, and lipid metabolism (54). A variety of immune functions are enhanced by
ascorbic acid (2), which could explain the concentration of the vitamin in the spleen.
128 / Peake
Figure 2 Role of ascorbic acid in the synthesis of (A) norepinephrine, (B) collagen, (C)
carnitine, and (D) the -amidation of neuropeptides (modified with permission from
79).
Vitamin C Status
The vitamin C status of individuals has been assessed using several different methods. Dietary intakes of ascorbic acid have been used for the general assessment and
prediction of vitamin C status. The correlation between plasma/serum ascorbic acid
concentration and dietary ascorbic acid intake is only modest (r = 0.320.55; 89).
One group failed to find any relationship (44). The normal ranges for plasma and
leukocyte ascorbic acid concentrations are listed in Table 2. There has been some
debate as to which component of whole blood provides the most reliable index of
vitamin C status and whether whole blood does in fact reflect the true tissue stores of
the vitamin (18, 29, 42, 53, 65). In two studies, the responses to supplementation
with vitamin C were similar between plasma and leukocytes (9, 55). Furthermore,
plasma and leukocyte ascorbic acid concentrations are correlated with each other
(15). In view of the inherent difficulties associated with measuring the ascorbic acid
content of internal organs in humans, a combination of measurement of dietary
intakes, plasma/serum, and leukocyte ascorbic acid concentrations appears to be the
best available indication of vitamin C status.
Body pool
(mg)
Plasma
mol/L
(mg/dL)
Mixed leucocytes
g/108 cells
(nmol/108 cells)
Mononuclear
leucocytes g/108 cells
(nmol/108 cells)
5001500
(1022 mg/kg)
2384
(0.41.5)
114301
(2053)
142250
(2544)
130 / Peake
intakes in athletes are reported to range from 90 to 140 mg per day. Intakes were
even higher in those athletes taking vitamin C supplements, which in one study was
found to be the most commonly used supplement among a large number of athletes
(34). Others have compared the intakes of exercising individuals with those of
sedentary controls and have generally observed higher intakes within the athletic
population (33, 34, 44, 81, 89).
Several studies have examined vitamin C intakes in athletes from a variety of
sports (25, 44, 89, 96). The results from a 24-h dietary recall suggested wide variation among sports, with some indication of seasonal variation, but no consistent
trends emerged (96). Low intakes have been observed in male gymnasts and wrestlers (96), and also in female athletes (25). In contrast to these findings, the results
from another study indicated very little difference in 1- or 7-day vitamin C intakes
among athletes from different sports, including wrestlers (96). Lower intakes in
some athletes may reflect dietary interventions directed at weight control in these
athletes, as it has been demonstrated that vitamin C intakes are related to total energy
intakes (34). Therefore, the amount of vitamin C in the diets of most athletes appears
to be sufficient, based on the recommended daily allowance. Another approach to
measuring vitamin C status has been to examine the response of plasma or serum
ascorbic acid concentrations to supplementation with varying doses of vitamin C.
Supplementation Studies
Athletes have been given vitamin C supplements ranging from 85 to 1500 mg
vitamin C, for periods of 1 day up to 8 months (5, 44, 58, 69, 76, 81, 83, 98, 106). The
effects of supplementation on both resting and exercise-induced changes in ascorbic acid concentration have been investigated (Table 3). There was little or no effect
of supplementation on plasma or serum ascorbic acid concentrations in several
studies (48, 58, 95, 98), whereas others have demonstrated increases in the concentration of ascorbic acid in blood following supplementation (5, 44, 69, 90, 106).
However, there are several issues to consider when interpreting these results.
The dose of vitamin C in the supplement, the regular dietary intakes of vitamin
C, and the concentration of ascorbic acid within plasma/serum and leukocytes prior
to supplementation would all appear to be important determinants of the response to
supplementation. Plasma ascorbic acid concentrations in one study plateaued at
vitamin C intakes of 250 mg and above per day, whereas the ascorbic acid content of
neutrophil, monocytes, and lymphocytes plateaued at lower intakes of 200 mg per
day (64). In another study, the optimal intake for absorption capacity was reported to
be 3 mg vitamin C per kilogram of body weight per day (89). The athletes in many of
the studies in Table 3 were receiving 200 mg of vitamin C per day in total.
Therefore, plasma/serum levels were likely close to saturation. Himmelstein et al.
(48) have reported that the athletes in their study had higher total dietary intakes of
vitamin C than sedentary individuals and consequently showed a smaller response
to supplementation. Similarly, Thompson et al. (101) observed a modest but significant increase in plasma ascorbic acid concentration but no change in the ascorbic
acid of lymphocytes following 2 weeks of supplementation with 400 mg vitamin C
per day. The mean (SD) dietary intake of vitamin C prior to supplementation was
147 (70) mg per day, and this level of intake was offered in explanation for the lack
of change in lymphocyte ascorbic acid content with supplementation.
1 month
2 weeks
500-mg placebo
200-mg placebo
1000-mg placebo
1000-mg placebo
1000-mg placebo
1000-mg placebo
Runners (n = 10)
Runners (n = 16)
Runners (n = 41)
Runners (n = 30)
Inactive (n = 29)
Inactive (n = 35)
227 ( 226) mg
312 ( 360) mg
378 ( 518) mg
442 ( 457) mg
ND
ND
ND
ND
201 ( 205) mg
320 ( 257) mg
ND
ND
ND
Plasma
Plasma
Plasma
Plasma
Serum
Plasma
Serum
Serum
Plasma
Serum
Whole blood
Blood
compartment
51 ( 19)
62 ( 22)
83 ( 10)
78 ( 13)
50.0 ( 53.0)
42.6 ( 33.3)
40.0 ( 21.4 )
34.0 ( 16.0)
49.1 ( 22.3)
52.9 ( 23.1)
76.3 ( 34.8)
53.3 ( 12.4)
ND
ND
67.0 ( 22.8)
73.3 ( 28.9)
ND
ND
Presupplement
52 ( 14)
72 ( 16)
80 ( 10)
80 ( 10)
69.8 ( 80.0)*
43.1 ( 29.4)
66.0 ( 29.5 )*
35.0 ( 16.0 )
47.0 ( 45.0)
15.4 ( 10.9)*
112.5 ( 36.3)*
56.2 ( 18.1)
55.7 ( 22.6)a
101.0 ( 16.1)
101.0 ( 22.2)
76.0 ( 17.0)a
57.3 ( 17.0)
Postsupplement
(48)
(90)
(84)
(95)
(69)
(98)
(44)
(106)
Ref.
Note. ND = no data available. *Significantly different compared to placebo (p < .01); significant increase (p < .05); significant increase (p = .005).
Placebo group used as comparison for effect of supplementation; bathletes from a variety of sports.
2 months
2 months
2 months
2 months
4.5 weeks
3 weeks
400-mg placebo
Inactive (n = 8)
Athletes (n = 86)
78 months
94.9 ( 17.5) mg
ND
550-mg placebo
1 month
108.7 ( 56.6) mg
Athletes (n = 86)b
200 mg
Athletes (n = 55)b
3 months
Dietary intake
87.8 ( 50.6) mg
85-mg placebo
Runners (n = 30)
Supplementation period
Inactive (n = 20)
Supplement
Mean (SD) Changes in Ascorbic Acid Concentration Following Dietary Supplementation Including Vitamin C
Subjects
Table 3
132 / Peake
The dietary intakes were also similar between the two groups. The fact that the
athletes did not exhibit a greater response to supplementation is suggestive that
regular exercise does not actually increase the requirement for ascorbic acid. Nevertheless, it is reasonable to contend that through its utilization in metabolic pathways
such as carnitine, noradrenaline, and collagen synthesis and antioxidant reactions,
athletes may require more vitamin C than sedentary individuals. At similar dietary
intakes, athletes may use a greater proportion of the vitamin C consumed in their diet
than nonathletes. Nonathletes may not need all of the vitamin C they consume and
may excrete the excess. In such a way, athletes would actually have increased
requirements. However, two studies of the ascorbic acid content in urine revealed no
difference between athletes and sedentary controls (32, 89).
In conclusion, the majority of existing data from dietary and supplementation
studies do not support the concept that athletes have increased requirements for
vitamin C for the following reasons. First, the dietary intake of athletes and sedentary controls is similar, as is the response to supplementation with vitamin C. Second, there does not appear to be a strong association between dietary intakes of
vitamin C and the concentration of ascorbic acid within the blood. Last, the
excretion of ascorbic acid in urinewhich may be taken as an assessment of
the utilization of vitamin C within the bodydoes not differ between athletes
and nonathletes.
Untrained (n = 24)
Untrained (n = 8)
Ironman triathlon
Marathon
Half-marathon
Half-marathon
Cyclists (n = 11)
Triathletes (n = 39)
Runners (n = 8)
Runners (n = 9)
Runners (n = 7)
Activity
Plasma
Plasma
Lymphocytes
Plasma
Lymphocytes
Plasma
Plasma
Plasma
Serum
Blood
compartment
( 12.4)p
( 20.9)c
( 46.4)e
( 2.27)
( 21.2)p
( 20.6)c
( 56.6)e *
( 2.27)
38.4 ( 15.3)
52.7 ( 12.3)
15.6 ( 1.80)a
54.7 ( 26.6)
17.4 ( 3.96)a
51.5 ( 26.2)*
67.0 ( 15.9)
19.9 ( 2.70)a
79.0 ( 34.7)*
21.3 ( 7.35)a
95.4 ( 23.3)
94.8 ( 35.8)
96.0 ( 26.7)
98.9 ( 35.8)
48.1 ( 29.5)
10.8 ( 2.27)*
59.6
140.4
110.4
19.3
Post-exercise
41.1 ( 25.2)
18.2 ( 2.95)
53.3
112.5
99.9
21.0
Pre-exercise
Subjects
Table 4
(42)
(28)
(continued)
(41)
(104)
(16)
(69)
Ref.
Corrected
for HC
134 / Peake
Plasma
Marathon
Ultramarathon
Ultramarathon
Ultramarathon
Ultramarathon
Runners (n = 11)
Runners (n = 29)
Runners (n = 20)
Runners (n = 29)
Runners (n = 16)
Runners (n = 28)
103 ( 33.2)
134 ( 19.9)p
150 ( 14.8)c
161 ( 6.81)c
42.0 ( 21.4)p
95 ( 39.1)c,e
125 ( 22.0)p
145 ( 35.0)c
146 ( 30.0)c
116 ( 15.9)c
107 ( 11.9)p
183 ( 14.2)c
73.8 ( 8.5)p
82.9 ( 10.8)p
128 ( 10.2)c
153 ( 10.2)c
35.0 ( 16.0)p
66 ( 29.5)c,e
82 ( 40.0)p
130 ( 35.0)c
150 ( 40.0)c
118 ( 15.9)c
85.8 ( 11.9)p
69.8 ( 8.50)c
39.7 ( 6.8)p
56.8 ( 52.0)p
105.6 ( 117) c,e
41.9 ( 25.2)p
72.8 ( 55.2)c,e
86.0 ( 33.2)
Post-exercise
Pre-exercise
ND
(77)
(83)
(82)
(84)
(76)
(66)
(90)
Ref.
Corrected
for HC
Note. ND = no available data, HC = haemoconcentration. *Significant (p < .05); significant (p < .01); significant (p < .001); significant (p < .05)
versus placebo. aConcentration expressed as mol g1 of protein; cvitamin Csupplemented group; evitamin Esupplemented group; pplacebo group.
Plasma
Serum
Serum
Plasma
Serum
Serum
Marathon
Runners (n = 16)
Blood
compartment
Activity
(continued)
Subjects
Table 4
136 / Peake
and is therefore not directly involved in the protection of LDL against oxidation, it
does neutralize free radicals that can lead to oxidation of LDL (36) through mechanisms explained below. Hence, the decline in plasma ascorbic acid content observed
in the days following the marathon (66) may be attributed to the consumption of
ascorbic acid in oxidative reactions contributing to LDL oxidation. Alternatively, it
could also reflect the involvement of ascorbic acid in maintaining -tocopherol in a
reduced state (57)the plasma concentration of which was unchanged 4 days after
the marathon (66). Further research is warranted to confirm these concepts.
The reasons for differences with regard to exercise-induced changes between
these studies are not immediately clear, but some suggestions may be offered.
Differences in assay techniques to measure plasma ascorbic acid concentrations
may have contributed to the variability of findings between studies. Alternatively,
the validity of measuring ascorbic acid in the plasma or serum compared to leukocyte concentrations has been questioned (70, 88).
Differences in the extent of oxidative stress caused by exercise could also
have been a factor. Many of the studies in Table 4 involved prolonged endurance
exercise, which is likely to cause an increase in oxidative stress (28, 40, 66, 90), and
it has been suggested that oxidative stress is a stimulus for the release of ascorbic
acid from the adrenal gland (82). During exercise, it has been proposed that a prooxidant-antioxidant equilibrium is in operation, and that the intensity of exercise is
the critical factor in determining alterations in this equilibrium (110). It is possible
that differences in the degree of oxidative stress induced by exercise among the
studies might have caused some variation in the amount of ascorbic acid released. If
this concept is in fact true, then it follows logically that pre-exercise plasma/serum
ascorbic acid concentrations would also influence the extent of exercise-induced
oxidative stress and consequently, the magnitude of ascorbic acid release during
exercise in response to any oxidative challenge. Among the studies in Table 4, there
is partial support for this idea. When pre-exercise plasma/serum ascorbic acid concentrations were in the middle of the range (i.e., 4060 mol/L), there was an
increase in plasma/serum ascorbic acid (28, 41, 42, 69, 77, 90). In contrast,
when pre-exercise plasma/serum ascorbic acid concentrations were at the high end
of the range (i.e., 80 mol/L), less ascorbic acid was released (40, 66, 69). This was
particularly apparent in those studies involving supplementation (76, 82, 83).
There is also tentative evidence for an exercise mode effect on the magnitude
of changes in plasma ascorbic acid concentration. Among cyclists and triathletes the
increase was modest (40, 104), whereas among runners plasma ascorbic acid levels
appear to be elevated to a greater extent (41, 42, 66, 76, 82, 83, 90). Considering that
there are no existing data with respect to the possible effect(s) of exercise mode on
the degree of oxidative stress, the differences above cannot be reconciled on the
basis of differences in exercise-induced oxidative stress. Differences in tissue damage resulting from each form of exercise also seem an unlikely influence, in light of
the recent findings that supplementation with vitamin C did not influence inflammatory reactions to exercise-induced muscle damage (77, 84). Therefore, it remains to
be determined what exercise factors (i.e., intensity, duration, mode) affect changes
in plasma ascorbic acid during exercise. Future exercise studies could investigate
possible differences between different forms of exercise with respect to alterations
in antioxidant capacity and oxidative stress.
138 / Peake
gland upon ACTH stimulation. Freeman (35) has reported that 1 hour after the
injection of ACTH, relative to chickens not supplemented with vitamin C, there was
a greater increase in plasma corticosteroid concentrations in those chickens receiving additional vitamin C in their diet.
In another study by the same group, the vitamin C content of diets fed to
guinea pigs was manipulated, injections of ACTH were administered to the animals,
and the resultant alterations in adrenal ascorbic acid and plasma cortisol concentrations were measured (63). Although dietary vitamin C strongly influenced the concentration of ascorbic acid in the adrenal glands, it was without effect on basal or
ACTH-stimulated changes in plasma cortisol. Furthermore, among the animals
treated with ACTH, only a weak association was found between adrenal ascorbic
acid and plasma cortisol concentrations. Last, similarly to earlier findings (60),
ACTH treatment did not influence plasma ascorbic acid concentrations. Taken
together these data indicate that the absolute concentration of ascorbic acid within
the adrenal gland is not critical for the synthesis of cortisol (63). While ascorbic acid
is required for the synthesis of cortisol, ascorbic acid does not appear to be released
simultaneously with cortisol as a stress response.
In 1962, Jenkins (56) demonstrated a role for ascorbic acid in the synthesis of
cortisol, specifically in the terminal step of the conversion of 11-deoxycortisol to
cortisol (Figure 3). This finding was supported more recently by Moser (71) who
140 / Peake
cultured porcine adrenal cells for one week with and without 50 mol/L ascorbic
acid and stimulated the cells on days 2, 3, and 4 with ACTH. While the release of
cortisol on day 2 was not dependent on ascorbic acid, on days 3 and 4, the amount of
cortisol produced was significantly higher in those cells cultured with ascorbic acid.
In contrast, there was a marked decline in cortisol release after repetitive stimulation
in the cells cultured without ascorbic acid. Hence, ascorbic seems to be a critical
factor in the synthesis of cortisol. It has since been shown that ascorbic acid exerts its
influence in this process by acting as an antioxidant in this process, which stands to
reason considering the high concentration of ascorbic acid within the adrenal gland
(49). The transfer of electrons between NADPH, adrenodoxin reductase, adrenodoxin
and CYP11A1, produces superoxide radicals (46), which may impair the activity of
CYP11B1 (11--hydroxylase). Hornsby et al. (50) demonstrated that when primary
bovine adrenocortical cells were cultured in a serum-free medium, the addition of
cortisol as a pseudosubstrate caused a decline in 11--hydroxylase activity. However, in the presence of 50 mol/L cortisol, the addition of 5 mmol/L ascorbic acid
almost completely prevented this loss of 11--hydroxylase activity. This effect was
synergistic with low oxygen in the culture medium. Hence, rather than stimulating
steroidogenesis per se, ascorbic acid appears to act by protecting cytochromes, such
as CYP11B1.
Several other groups have subsequently investigated the possible relationship
between the release of ascorbic acid and cortisol during exercise by supplementing
athletes with 5001500 mg vitamin C in the week before, and on the day of, an
ultramarathon (76, 82, 83). In each of these studies, vitamin C caused a significant
increase in pre-race plasma/serum ascorbic acid concentrations and significantly
attenuated the post-exercise serum cortisol responses, relative to the placebo group.
In contrast to the work of Gleeson et al. (42), modest negative correlations have been
reported between changes in plasma/serum ascorbic acid and cortisol postexercise
(76, 77, 83). These findings are supported by other studies not involving athletes.
Supplementation with 1000 mg vitamin C for 16 weeks caused a significant reduction in resting serum cortisol concentrations in aged women with coronary heart
disease, but not in healthy age-matched controls (22). Patients who were given 1000
mg vitamin C while under anesthetic demonstrated a transient suppression of blood
ACTH and cortisol concentrations (73).
In accounting for these findings, it has been suggested that ascorbic acid is
utilized during exercise to counter oxidative stress, while cortisol is released to
counter inflammatory reactions resulting from exercise-induced muscle damage
(82). Oxidative stress has been implicated in chronic inflammation. The findings of
De la Fuente et al. (22) outlined above, are supportive of a link between oxidative
stress and inflammation. Under some conditions and in certain cell lines, a shift in
the glutathione redox state can activate NFB (26). It is unknown whether there is a
signal transduction pathway directly linking alterations in the glutathione redox
state with the release of cortisol, or if increases in ascorbic acid and cortisol with
exercise are incidental. Certainly, it is tempting to support the concept that oxidative
stress is a stimulus for the release of cortisol during exercise, particularly on the
basis that elevated plasma ascorbic acid concentrationswhich presumably signaled adequate antioxidant defense capacityattenuated the cortisol response (76,
82, 83). Nevertheless, it must be questioned whether there is in fact a link between
oxidative stress reactions and the inflammatory response to exercise-induced muscle
damage (77, 84).
Figure 4 Proposed relationship between exercise-induced oxidative stress and inflammatory responses to muscle damage.
Despite the attenuation of cortisol release following vitamin C supplementation, this effect may actually have promoted the inflammatory response (see Figure
4), as indicated by significantly higher levels of acute phase reactants such as Creactive protein and creatine kinase (83), and significantly reduced concentrations
of anti-inflammatory cytokines such as interleukin-1 receptor antagonist and
interleukin-10 (76, 82). Another group demonstrated that supplementation with a
smaller dose of vitamin C (400 mg) for 2 weeks prior to exercise did not alter the
cortisol response, yet the postexercise plasma concentration of the anti-inflammatory cytokine interleukin-6 was significantly reduced (101). Therefore, it seems
unlikely that exercise-induced oxidative stress causes the release of cortisol from
the adrenal gland, at least not in order to counter inflammation. However, the effects
of vitamin C could depend on the supplementation dosage.
Two novel, yet largely speculative hypotheses are presented below to account
for the observation of attenuated postexercise cortisol levels following vitamin C
supplementation (76, 82, 83). High doses of vitamin C may inhibit the synthesis of
cortisol, possibly through pro-oxidant effects. Under certain conditions in vitro,
ascorbic acid may work as a pro-oxidant rather than as an antioxidant by reducing
transition metal ions (reaction 1), which in turn drives the Fenton reaction (reactions
2 and 3), potentially resulting in oxidative stress (45).
AH + Fe3+ A + Fe2+ + H+ (reaction 1)
(1)
(2)
(3)
142 / Peake
antioxidant N-acetylcysteine per kg body weight for 7 days prior to a brief, intense
session of eccentric resistance exercise. The plasma concentration of serum bleomycin
detectable iron was elevated in both groups in the days after exercise but was
significantly higher in the supplement group. Supplementation also significantly
increased plasma total antioxidant status. Importantly, there was evidence of oxidative stress. In the supplemented group, the plasma concentrations of 8isoprostaglandin F2 tended to be higher (p = .07), whereas lipid hydroperoxide
levels were significantly higher (p < .001). Although no correlations were reported,
it is tempting to speculate that the combination of increases in serum-free iron,
plasma antioxidant capacity, and lipid peroxidation markers were indicative of prooxidant effects of ascorbic acid during exercise. Unfortunately, plasma ascorbic
acid concentrations were not measured, as this may have provided further insight
into the mechanisms in operation. The interaction between Fe3+ and ascorbic acid
may depend on the ratio of ascorbic acid to dehydroascorbic acid (87). It is also
unknown if there was any effect of the N-acetylcysteine on plasma ascorbic acid
concentration (21).
Of interest to the current discussion is whether interactions between ascorbic
acid and iron could also influence the synthesis of cortisol in the adrenal gland
during exercise. There is evidence suggesting that oxidative conditions impair the
activity of the enzyme responsible for cortisol synthesis, 11--hydroxylase (50).
The production of superoxide anions by polymorphonuclear cells during exercise
(47) could possibly induce the release of catalytic iron from ferritin (86) and/or
myoglobin (85). The combined effects of elevated concentrations of serum-free
iron and ascorbic acid in the circulation during exercise could promote the formation of reactive oxidants (93), leading in turn to impaired activity of 11--hydroxylase and less synthesis of cortisol, which could possibly explain the recent findings
of Peters et al. (82, 83). In evidence against this novel hypothesis, Nieman et al. (77)
recently reported that vitamin C supplementation had no effect on plasma F2isoprostane and lipid hydroperoxide concentrations following an ultramarathon
race, yet postexercise serum cortisol correlated negatively with plasma ascorbic
acid (r = 0.50, p = .0006).
The second hypothesis offered presently is related to a possible role for ascorbic acid in glucose metabolism during exercise. Although ascorbic acid within the
adrenal gland may not influence ACTH activity and cortisol synthesis directly (63),
high concentrations of ascorbic acid in other tissues such as the liver could possibly
have a regulatory effect on the release of cortisol. The evidence for this concept
comes from a study by Kodama et al. (62) who investigated the effect of infusing a
glucose-electrolyte solution containing 200 mmol/L ascorbic acid over 1.5 h into a
male volunteer. The concentration of ascorbic acid in plasma rose above 1000
mol/L within 0.5 h, and began to decrease thereafter, reaching baseline 3 h later.
Interestingly, the decline in plasma ascorbic acid corresponded to a rapid and dramatic increase in plasma cortisol and ACTH concentrations. Kodama et al. proposed that the liver acts as a vitamin C/cortisol absorber for two reasons: First, the
liver contains high concentrations of ascorbic acid (49) and, second, both cortisol
(59) and possibly even ascorbic acid are involved in the regulation of carbohydrate
metabolism within the liver (11).
Using human erythrocytes as a model of peripheral tissues, Braun et al. (11)
demonstrated that the oxidized form of ascorbic acid, dehydroascorbic acid, is
converted to glucose-6-phosphate through the pentose phosphate pathway and/or
144 / Peake
protects low-density lipoprotein against oxidative stress reactions (37, 38). During
exercise, ascorbic acid likely exerts its antioxidant activity both directly and also in
concert with alpha-tocopherol and glutathione (Figure 5). The hydrogen atoms
produced in the oxidation of ascorbic acid first to ascorbyl radical and then to
dehydroascorbate (see Figure 1), react with a lipid peroxyl radical (LOO) to form
the non-radical product, LOOH. Trapping of LOO prevents this radical from attacking polyunsaturated fatty acid side chains (LH) and other lipoproteins in plasma,
and thereby halts the chain reaction of lipid peroxidation (reaction 4) (36).
LOO + L'H LOOH + L' (reaction 4)
(4)
Conclusions
Ascorbic acid is known to be involved in a number of metabolic pathways that are
important to exercise. Nevertheless, reports of alterations in the concentration of
ascorbic acid within plasma/serum or urine following vitamin C supplementation
and exercise do not support the concept that athletes have a greater requirement for
vitamin C in their diets. During acute exercise, it is commonly contended that the
major role of ascorbic acid is in counteracting oxidative stress. However, whether
ascorbic acid is oxidized to dehydroascorbic acid in these reactions during exercise
has not been investigated to date. Future exercise studies should investigate measuring the concentration of ascorbic acid derivatives, such as dehydroascorbic acid
following exercise. It is conceivable that ascorbic acid is efficiently recycled by
exercise, thereby obviating the need for supplementation beyond regular dietary
intakes. Two novel hypotheses have been put forward in this review. First, in addition to causing lipid peroxidation, the products of prooxidant reactions that potentially follow supplementation with high doses of vitamin C may have more wideranging effects on other aspects of physiological function. Second, although it has
been questioned whether cortisol is a factor in stimulating gluconeogenesis, there is
recent evidence that lends tentative support to the idea that both cortisol and ascorbic
acid have a regulatory influence on gluconeogenesis. These concepts await further
146 / Peake
References
1. Alessio, H.M., A.H. Goldfarb, and G. Cao. Exercise-induced oxidative stress before and
after vitamin C supplementation. Int. J. Sport. Nutr. 7:1-9, 1997.
2. Anderson, R. The immunostimulatory, anti-inflammatory and anti-allergic properties of
ascorbate. Adv. Nutr. Res. 6:19-45, 1984.
3. Anderson, R., M. Smit, G. Joone, and A. van Staden. Vitamin C and cellular immune
functions. Ann. N.Y. Acad. Sci. 587:33-48, 1989.
4. Aron, D., J. Findling, and J. Tyrrell. Glucocorticoids and adrenal androgens. In: Basic
and Clinical Endocrinology, F. Greenspan and D. Gardner (Eds.). New York: Lange
Medical Books/McGraw-Hill, 2001, pp. 338-339.
5. Ashton, T., I.S. Young, J.R. Peters, E. Jones, S.K. Jackson, B. Davies, and C.C. Rowlands.
Electron spin resonance spectroscopy, exercise, and oxidative stress: an ascorbic acid
intervention study. J. Appl. Physiol. 87:2032-2036, 1999.
6. Berger, T.M., M.C. Polidori, A. Dabbagh, P.J. Evans, B. Halliwell, J.D. Morrow, L.J.
Roberts, 2nd, and B. Frei. Antioxidant activity of vitamin C in iron-overloaded human
plasma. J. Biol. Chem. 272:15656-15660, 1997.
7. Bergholm, R., S. Makimattila, M. Valkonen, M.L. Liu, S. Lahdenpera, M.R. Taskinen,
A. Sovijarvi, P. Malmberg, and H. Yki-Jarvinen. Intense physical training decreases
circulating antioxidants and endothelium-dependent vasodilatation in vivo. Atherosclerosis. 145:341-349, 1999.
8. Bergsten, P., A.S. Moura, I. Atwater, and M. Levine. Ascorbic acid and insulin secretion
in pancreatic islets. J. Biol. Chem. 269:1041-1045, 1994.
9. Blanchard, J., K. Conrad, R. Watson, P. Garry, and J. Crawley. Comparison of plasma,
mononuclear and polymorphonuclear leucocyte vitamin C levels in young and elderly
women during depletion and supplementation. Eur. J. Clin. Nutr. 43:97-106, 1989.
10. Branch, D. High-dose vitamin C supplementation increases plasma glucose. Diabetes
Care. 22:1218-1219, 1999.
11. Braun, L., F. Puskas, M. Csala, G. Meszaros, J. Mandl, and G. Banhegyi. Ascorbate as a
substrate for glycolysis or gluconeogenesis: evidence for an interorgan ascorbate cycle.
Free Radic. Biol. Med. 23:804-808, 1997.
12. Bremer, J. Carnitinemetabolism and functions. Physiol. Rev. 63:1420-1480, 1983.
13. Brites, F., P. Evelson, M. Christiansen, M. Nicol, M. Basilico, R. Wikinski, and S.
Llesuy. Soccer players under regular training show oxidative stress but an improved
plasma antioxidant status. Clin. Sci. 96:381-385, 1996.
14. Buettner, G.R. The pecking order of free radicals and antioxidants: lipid peroxidation,
alpha-tocopherol, and ascorbate. Arch. Biochem. Biophys. 300:535-543, 1993.
15. Burr, M., P. Elwood, D. Hole, R. Hurley, and R. Hughes. Plasma and leucocyte ascorbic
acid levels in the elderly. Am. J. Clin. Nutr. 27:144-151, 1974.
16. Camus, G., A. Felekidis, J. Pincemail, G. Deby-Dupont, C. Deby, A. Juchmes-Ferir, R.
Lejeune, and M. Lamy. Blood levels of reduced/oxidised glutathione and plasma concentration of ascorbic acid during eccentric and concentric exercises at similar energy
cost. Arch. Int. Physiol. Biochim. Biophys. 102:67-70, 1994.
17. Carbajal, A., C. Nunez, and O. Moreiras. Energy intake as a determinant factor of
vitamin status in healthy young women. Int. J. Vitam. Nutr. Res. 66:227-231, 1996.
18. Castelli, A., G. Martorana, E. Meucci, and G. Bonetti. Vitamin C in normal human
mononuclear and polymorphonuclear leucocytes. Acta. Vitaminol. Enzymol. 4:189-196,
1982.
19. Child, R., D. Wilkinson, and J. Fallowfield. Effects of a training taper on tissue damage
indices, serum antioxidant capacity and half-marathon running performance. Int. J.
Sports Med. 21:325-331, 2000.
20. Child, R., D. Wilkinson, J. Fallowfield, and A. Donnelly. Elevated serum antioxidant
capacity and plasma malondialdehyde concentration in response to a simulated halfmarathon run. Med. Sci. Sports Exerc. 30:1603-1107, 1998.
21. Childs, A., C. Jacobs, T. Kaminski, B. Halliwell, and C. Leeuwenburgh. Supplementation with vitamin C and N-acetyl-cysteine increases oxidative stress in humans after an
acute muscle injury induced by eccentric exercise. Free Rad. Biol. Med. 31:745-753,
2001.
22. De la Fuente, M., M. Ferrandez, M. Burgos, A. Soler, A. Prieto, and J. Miquel. Immune
function in aged women is improved by ingestion of vitamins C and E. Can. J. Physiol.
Pharmacol. 76:373-380, 1998.
23. Delamere, N. Ascorbic acid and the eye. In: Ascorbic Acid: Biochemistry and Biomedical Cell Biology, J. Harris (Ed.). New York: Plenum, 1996, pp. 313-329.
24. Dhariwal, K., P. Washko, W. Hartzell, and M. Levine. Ascorbic acid within chromaffin
granules. In situ kinetics of norepinephrine biosynthesis. J. Biol. Chem. 264:1540415409, 1989.
25. Di Chen, J., J. Wang, K. Li, Y. Zhao, S. Wang, Y. Jiao, and X. Hou. Nutritional problems
and measures in elite and amateur athletes. Am. J. Clin. Nutr. 49:1084-1089, 1989.
26. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 82:4795, 2002.
27. Dugal, L., and M. Therein. Ascorbic acid and acclimatization to cold environment. Can.
J. Res. 25:111-136, 1947.
28. Duthie, G., J. Robertson, R. Maughan, and P. Morrice. Blood antioxidant status and
erythrocyte lipid peroxidation following distance running. Arch. Biochem. Biophys.
282:78-83, 1990.
29. Evans, R., L. Currie, and A. Campbell. The distribution of ascorbic acid between various
cellular components of blood, in normal individuals, and its relation to the plasma
concentration. Br. J. Nutr. 47:473-482, 1982.
30. Evans, W. Vitamin E, vitamin C, and exercise. Am. J. Clin. Nutr. 72:647S-652S, 2000.
31. Ferrandez, M., M. Maynar, and M. De la Fuente. Effects of a long-term training program
of increasing intensity on the immune function of indoor Olympic cyclists. Int. J. Sports
Med. 17:592-596, 1996.
32. Fishbaine, B., and G. Butterfield. Ascorbic acid status of running and sedentary men. Int.
J. Vit. Nutr. Res. 54:273, 1975. (Abstract)
33. Fogelholm, G. Micronutrient status in females during a 24-week fitness-type exercise
program. Ann. Nutr. Metab. 36:209-218, 1992.
34. Fogelholm, G., J.-J. Himberg, K. Alopaues, C.-G. Gref, J. Laakso, J. Lehto, and H.
Mussalo-Rauhamaa. Dietary and biochemical indices of nutritional status in male athletes and controls. J. Am. Coll. Nutr. 11:181-191, 1992.
35. Freeman, B. Ascorbic acid and adrenal cortical activity in the immature domestic fowl.
Comp. Biochem. Physiol. A. 67:183-186, 1980.
36. Frei, B. Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am. J.
Med. 97:3A-13S, 1994.
148 / Peake
37. Frei, B., L. England, and B. Ames. Ascorbate is an outstanding antioxidant in human
plasma. Proc. Natl. Acad. Sci. U.S.A. 86:6377-6381, 1989.
38. Frei, B., R. Stocker, and B. Ames. Antioxidant defenses and lipid peroxidation in human
blood plasma. Proc. Natl. Acad. Sci. U.S.A. 85:9748-9752, 1988.
39. Gerster, H. The role of vitamin C in athletic performance. J. Am. Coll. Nutr. 8:636-643,
1989.
40. Ginsburg, G., A. Agil, M. OToole, E. Rimm, P. Douglas, and N. Rifai. Effects of a single
bout of ultraendurance exercise on lipid levels and susceptibility of lipids to peroxidation
in triathletes. J. Am. Med. Assoc. 276:221-225, 1996.
41. Gleeson, M., and R. Maughan. Acute effect of exercise on ascorbate content of plasma
and lymphocytes. Proc. Nutr. Soc. 46:89A, 1986. (Abstract)
42. Gleeson, M., J. Robertson, and R. Maughan. Influence of exercise on ascorbic acid status
in man. Clin. Sci. 73:501-505, 1987.
43. Goldenberg, H., H. Landertshamer, and H. Laggner. Functions of vitamin C as a mediator of transmembrane electron transport in blood cells and related cell culture models.
Antiox. Redox Signal. 2:189-196, 2000.
44. Guilland, J.-C., T. Peneranda, C. Gallet, V. Boggio, F. Fuchs, and J. Klepping. Vitamin
status of young athletes including the effects of supplementation. Med. Sci. Sports Exerc.
21:441-449, 1989.
45. Halliwell, B. Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic Res. 25:439454, 1996.
46. Hanukoglu, I., R. Rapoport, L. Weiner, and D. Sklan. Electron leakage from the mitochondrial NADPH-adrenodoxin reductase- adrenodoxin-P450scc (cholesterol side chain
cleavage) system. Arch. Biochem. Biophys. 305:489-498, 1993.
47. Hessel, E., A. Haberland, M. Muller, D. Lerche, and I. Schimke. Oxygen radical generation of neutrophils: a reason for oxidative stress during marathon running? Clin. Chim.
Acta. 298:145-156, 2000.
48. Himmelstein, S., R. Robergs, K. Koehler, S. Lewis, and C. Qualls. Vitamin C supplementation and upper respiratory tract infections in marathon runners. J. Exerc. Physiol.
Online. 1:1998.
49. Hornig, D. Distribution of ascorbic acid, metabolites and analogues in man and animals.
Ann. NY Acad. Sci. 258:103-118, 1975.
50. Hornsby, P.J., S.E. Harris, and K.A. Aldern. The role of ascorbic acid in the function of
the adrenal cortex: studies in adrenocortical cells in culture. Endocrinology. 117:12641271, 1985.
51. Hughes, R., and P. Nicholas. Effects of caging on the ascorbic acid content of the adrenal
glands of the guinea-pig and gerbil. Life Sci. 10:53-55, 1971.
52. Hume, R., and E. Weyers. Changes in leucocyte ascorbic acid during the common cold.
Scott. Med. J. 18:3-7, 1973.
53. Jacob, R. Assessment of human vitamin C status. J. Nutr. 120:1480-1485, 1990.
54. Jacob, R. Vitamin C. In: Modern Nutrition in Health and Disease, M. Shils, J. Olson and
M. Shike (Eds.). Hagerstown, MD: Williams & Wilkins, 1994, pp. 432-448.
55. Jacob, R., J. Skala, and S. Omaye. Biochemical indices of human vitamin C status. Am. J.
Clin. Nutr. 46:818-826, 1987.
56. Jenkins, J. The effect of ascorbic acid on adrenal steroid synthesis in vitro. Endocrinology. 70:267-271, 1962.
57. Kagan, V.E., E.A. Serbinova, T. Forte, G. Scita, and L. Packer. Recycling of vitamin E in
human low density lipoproteins. J. Lipid Res. 33:385-397, 1992.
58. Kanter, M., L. Nolte, and J. Holloszky. Effects of an antioxidant vitamin mixture on lipid
peroxidation at rest and post-exercise. J. Appl. Physiol. 74:965-969, 1993.
59. Khani, S., and J.A. Tayek. Cortisol increases gluconeogenesis in humans: its role in the
metabolic syndrome. Clin Sci. 101:739-747, 2001.
60. Kipp, D., and J. Rivers. Uptake and release of ascorbic acid in the guinea pig after
injection of ACTH. J. Nutr. 117:1570-1575, 1987.
61. Kitabchi, A.E. Ascorbic acid in steroidogenesis. Nature. 215:1385-1386, 1967.
62. Kodama, M., T. Kodama, M. Murakami, and M. Kodama. Vitamin C infusion treatment
enhances cortisol production of the adrenal via the pituitary ACTH route. In Vivo.
8:1079-1086, 1994.
63. Laney, P., J. Levy, and D. Kipp. Plasma cortisol and adrenal ascorbic acid levels after
ACTH treatment with a high intake of ascorbic acid in the guinea pig. Ann. Nutr. Metab.
34:85-92, 1990.
64. Levine, M., C. Conry-Cantilena, D. Wang, R. Welch, P. Washko, K. Dhariwal, J. Park,
A. Lazarev, J. Graumlich, J. King, and L. Cantilena. Vitamin C pharmacokinetics in
healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad.
Sci. U.S.A. 93:3704-3709, 1996.
65. Levine, M., and W. Hartzell. Ascorbic acid: the concept of optimum requirements. Ann.
NY Acad. Sci. 498:424-444, 1987.
66. Liu, M.-L., R. Bergholm, S. Kimattila, S. Lahdenpera, M. Valkonen, H. Hilden, H. YkiJarvinen, and M.-R. Taskinen. A marathon run increases the susceptibility of LDL to
oxidation in vitro and modifies plasma antioxidants. Am. J. Physiol. 276:E1083-E1091, 1999.
67. Lynch, S., J. Gaziano, and B. Frei. Ascorbic acid and atherosclerotic cardiovascular
disease. In: Ascorbic Acid: Biochemistry and Biomedical Cell Biology, J. Harris (Ed.).
New York: Plenum, 1996, pp. 331-367.
68. Maritz, G. Ascorbic acid. Protection of lung tissue against damage. In: Ascorbic Acid:
Biochemistry and Biomedical Cell Biology, J. Harris (Ed.). New York: Plenum, 1996,
pp. 265-291.
69. Maxwell, S., P. Jakeman, C. Leugen, and G. Thorpe. Changes in plasma antioxidant
status during eccentric exercise and the effect of vitamin supplementation. Free Rad.
Res. Comm. 19:191-202, 1993.
70. Meydani, M., W.J. Evans, G. Handelman, L. Biddle, R.A. Fielding, S.N. Meydani, J.
Burrill, M.A. Fiatarone, J.B. Blumberg, and J.G. Cannon. Protective effect of vitamin E
on exercise-induced oxidative damage in young and older adults. Am. J. Physiol. 264:R992R998, 1993.
71. Moser, U. Physiology and metabolism of ascorbic acid. In: Ascorbic Acid in Domestic
Animals: Proceedings of the Second Symposium, C. Wenk, R. Fenster, and L. Volker
(Eds.). Basel: F Hoffman-La Roche, 1992, pp. 3-16.
72. Murthy, A.S., H.T. Keutmann, and B.A. Eipper. Further characterization of
peptidylglycine alpha-amidating monooxygenase from bovine neurointermediate pituitary. Mol. Endocrinol. 1:290-299, 1987.
73. Nathan, N., J. Vandroux, and P. Feiss. Role of vitamin C on adrenocortical effects of
etomidate. Ann. Fr. Anesth. Reanim. 10:329-332, 1991.
74. Nelson, P.J., R.E. Pruitt, L.L. Henderson, R. Jenness, and L.M. Henderson. Effect of
ascorbic acid deficiency on the in vivo synthesis of carnitine. Biochim. Biophys. Acta.
672:123-127, 1981.
75. Nieman, D., J. Butler, L. Pollett, S. Dietrich, and R. Lutz. Nutrient intake of marathon
runners. J. Am. Diet. Assoc. 89:1273-1278, 1989.
150 / Peake
76. Nieman, D., E.M. Peters, D. Henson, E. Nevines, and M. Thompson. Influence of vitamin C supplementation on cytokine changes following an ultramarathon. J. Interferon
Cytokine Res. 20:1029-1035, 2000.
77. Nieman, D.C., D.A. Henson, S. McAnulty, L. McAnulty, N. Swick, A. Utter, D. Vinci,
S.J. Opiela, and J.D. Morrow. Influence of vitamin C supplementation on oxidative and
immune changes after an ultramarathon. J. Appl. Physiol. 92:1970-1977, 2002.
78. Norris, J. The scurvy disposition: heavy exertion as an exacerbating influence on
scurvy in modern times. Bull. Hist. Med. 57:325-338, 1983.
79. Padh, H. Cellular functions of ascorbic acid. Biochem. Cell Biol. 68:1166-1173, 1990.
80. Park, J.B., and M. Levine. Purification, cloning and expression of dehydroascorbic acidreducing activity from human neutrophils: identification as glutaredoxin. Biochem. J.
315:931-918, 1996.
81. Peters, E., J. Goetzsche, B. Grobbelaar, and T. Noakes. Vitamin C supplementation
reduces the incidence of post-race symptoms of upper respiratory tract infection in
ultradistance runners. Am. J. Clin. Nutr. 57:170-174, 1993.
82. Peters, E.M., R. Anderson, D.C. Nieman, H. Fickl, and V. Jogessar. Vitamin C supplementation attenuates the increases in circulating cortisol, adrenaline and anti-inflammatory polypeptides following ultramarathon running. Int. J. Sports Med. 22:537-543,
2001a.
83. Peters, E.M., R. Anderson, and A.J. Theron. Attenuation of increase in circulating cortisol and enhancement of the acute phase protein response in vitamin C-supplemented
ultramarathoners. Int. J. Sports Med. 22:120-126, 2001b.
84. Petersen, E.W., K. Ostrowski, T. Ibfelt, M. Richelle, E. Offord, J. Halkjaer-Kristensen,
and B.K. Pedersen. Effect of vitamin supplementation on cytokine response and on
muscle damage after strenuous exercise. Am. J. Physiol. 280:C1570-C1575, 2001.
85. Prasad, M.R., R.M. Engelman, R.M. Jones, and D.K. Das. Effects of oxyradicals on
oxymyoglobin. Deoxygenation, haem removal and iron release. Biochem J. 263:731736, 1989.
86. Reif, D.W. Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med.
12:417-427, 1992.
87. Retsky, K.L., M.W. Freeman, and B. Frei. Ascorbic acid oxidation product(s) protect
human low density lipoprotein against atherogenic modification. Anti- rather than
prooxidant activity of vitamin C in the presence of transition metal ions. J. Biol. Chem.
268:1304-1309, 1993.
88. Roberston, J., R. Maughan, G. Duthie, and P. Morrice. Increased blood antioxidant
systems of runners in response to training load. Clin. Sci. 80:611-618, 1991.
89. Rokitzki, L., S. Hinkel, C. Klemp, D. Cufi, and J. Keul. Dietary, serum and urine ascorbic
acid status in male athletes. Int. J. Sports Med. 15:435-440, 1994a.
90. Rokitzki, L., E. Logemann, A. Sagredos, M. Murphy, W. Wetzel-Roth, and J. Keul.
Lipid peroxidation and antioxidative vitamins under extreme endurance stress. Acta
Physiol. Scand. 151:149-158, 1994b.
91. Rumsey, S., and M. Levine. Absorption, transport, and disposition of ascorbic acid in
humans. Nutr. Biochem. 9:116-130, 1998.
92. Rumsey, S.C., O. Kwon, G.W. Xu, C.F. Burant, I. Simpson, and M. Levine. Glucose
transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J. Biol. Chem.
272:18982-18989, 1997.
93. Samuni, A., J. Aronovitch, D. Godinger, M. Chevion, and G. Czapski. On the cytotoxicity of vitamin C and metal ions. A site-specific Fenton mechanism. Eur. J. Biochem.
137:119-124, 1983.
94. Sanchez-Quesada, J.L., O. Jorba, A. Payes, C. Otal, R. Serra-Grima, F. GonzalezSastre, and J. Ordonez-Llanos. Ascorbic acid inhibits the increase in low-density lipoprotein (LDL) susceptibility to oxidation and the proportion of electronegative LDL
induced by intense aerobic exercise. Coron. Artery Dis. 9:249-255, 1998.
95. Schroder, H., E. Navarro, A. Tramullas, J. Mora, and D. Galiano. Nutrition antioxidant
status and oxidative stress in professional basketball players: effects of a three compound antioxidative supplement. Int. J. Sports Med. 21:146-150, 2000.
96. Short, S., and W. Short. Four-year study of university athletes dietary intake. J. Am.
Diet. Assoc. 82:632-645, 1983.
97. Starkie, R.L., J. Rolland, D.J. Angus, M.J. Anderson, and M.A. Febbraio. Circulating
monocytes are not the source of elevations in plasma IL-6 and TNF-alpha levels after
prolonged running. Am. J. Physiol. 280:C769-C774, 2001.
98. Telford, R., E. Catchpole, V. Deakin, A. McLeay, and A. Plank. The effect of 7 to 8
months of vitamin/mineral supplementation on the vitamin and mineral status of athletes. Int. J. Sport Nutr. 2:123-134, 1992.
99. Thaxton, J., and S. Pardue. Ascorbic acid and physiological stress. In: Ascorbic Acid in
Domestic Animals, I. Wegger, F. Tagwerker, and J. Moustgaard (Eds.). Copenhagen:
The Royal Danish Agricultural Society, 1984, pp. 25-31.
100. Thompson, D., C. Williams, M. Kingsley, C.W. Nicholas, H.K. Lakomy, F. McArdle,
and M.J. Jackson. Muscle soreness and damage parameters after prolonged intermittent shuttle-running following acute vitamin C supplementation. Int. J. Sports Med.
22:68-75, 2001.
101. Thompson, D., C. Williams, S.J. McGregor, C.W. Nicholas, F. McArdle, M.J. Jackson,
and J.R. Powell. Prolonged vitamin C supplementation and recovery from demanding
exercise. Int. J. Sport. Nutr. Exerc. Met. 11:466-481, 2001.
102. Umegaki, K., P. Daohua, A. Sugisawa, M. Kumara, and M. Higuchi. Influence of one
bout of vigorous exercise on ascorbic acid in plasma and oxidative damage to DNA in
blood cells and muscle in untrained rats. J. Nutr. Biochem. 11:401-407, 2000.
103. Vasankari, T., U. Kujala, S. Sarna, and M. Ahotupa. Effects of ascorbic acid and
carbohydrate ingestion on exercise induced oxidative stress. J. Sports Med. Phys.
Fitness. 38:281-285, 1998.
104. Viguie, C., B. Frei, M. Shigenega, B. Ames, L. Packer, and G. Brooks. Antioxidant
status and indexes of oxidative stress during consecutive days of exercise. J. Appl.
Physiol. 75:566-572, 1993.
105. Washko, P., and M. Levine. Inhibition of ascorbic acid transport in human neutrophils
by glucose. J. Biol. Chem. 267:23568-23574, 1992.
106. Weight, L., T. Noakes, D. Labadarios, J. Graves, P. Jacobs, and P. Berman. Vitamin and
mineral status of trained athletes including the effects of supplementation. Am. J. Clin.
Nutr. 47:186-191, 1988.
107. Welch, R., Y. Wang, A.J. Crossman, J. Park, K. Kirk, and M. Levine. Accumulation of
vitamin C (ascorbate) and its metabolite dehydroascorbic acid occurs by separate
mechanisms. J. Biol. Chem. 270:12584-12592, 1995.
108. Whitney, E., and S. Rolfes. Understanding Nutrition. St Paul, MN: West Publishing,
1993.
109. Winkler, B., S. Orselli, and T. Rex. The redox couple between glutathione and ascorbic
acid: a chemical and physiological perspective. Free Rad. Biol. Med. 17:333-349,
1994.
110. Zembron-Lacny, A., and K. Szyszka. Exercise modification of the prooxidantantioxidant equilibrium. Med Sportiva. 4: 247-255, 2000.